Overview

A Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema

Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
A Phase I Trial of GW572016, Gemcitabine and Oxaliplatin for Metastatic Pancreaticobiliary Cancer Schema
Phase:
Phase 1
Details
Lead Sponsor:
Brown University
Collaborator:
GlaxoSmithKline
Treatments:
Gemcitabine
Lapatinib
Oxaliplatin